These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 20536989

  • 1. Role of anti-idiotypic antibodies in immune tolerance induction.
    Gilles JG.
    Haemophilia; 2010 May; 16(102):80-3. PubMed ID: 20536989
    [Abstract] [Full Text] [Related]

  • 2. Association of anti-idiotypic antibodies with immune tolerance induction for the treatment of hemophilia A with inhibitors.
    Sakurai Y, Shima M, Tanaka I, Fukuda K, Yoshida K, Yoshioka A.
    Haematologica; 2004 Jun; 89(6):696-703. PubMed ID: 15194537
    [Abstract] [Full Text] [Related]

  • 3. Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance.
    Reipert BM, Sasgary M, Ahmad RU, Auer W, Turecek PL, Schwarz HP.
    Thromb Haemost; 2001 Dec; 86(6):1345-52. PubMed ID: 11776297
    [Abstract] [Full Text] [Related]

  • 4. Epitope specificity of anti-factor VIII antibodies from inhibitor positive acquired and congenital haemophilia A patients using synthetic peptides spanning A and C domains.
    Gharagozlou S, Sharifian RA, Khoshnoodi J, Karimi K, Milani M, Okita DK, Shokri F, Conti-Fine BM.
    Thromb Haemost; 2009 May; 101(5):834-9. PubMed ID: 19404535
    [Abstract] [Full Text] [Related]

  • 5. Factor VIII-specific B cell responses in haemophilia A patients with inhibitors.
    van Helden PM, Van Haren SD, Fijnvandraat K, van den Berg HM, Voorberg J.
    Haemophilia; 2010 May; 16(102):35-43. PubMed ID: 20536984
    [Abstract] [Full Text] [Related]

  • 6. Reactivity profile of anti-factor VIII antibodies with designed synthetic peptides mimicking epitopes of the C2 and a1 domains.
    Chaves DG, Velloso-Rodrigues C, Moreau V, Nguyen C, Villard S, Belisário AR, Granier C, Santoro MM.
    Br J Haematol; 2008 May; 141(5):708-15. PubMed ID: 18422780
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Characterization of human hybridoma clones isolated from hemophilia patients with specificity for different domains of coagulating factor VIII.
    Gharagozlou S, Ghods R, Bahrami ZS, Roohi A, Jeddi-Tehrani M, Conti-Fine BM, Sharifian RA, Rabbani H, Shokri F.
    Hum Antibodies; 2003 May; 12(3):67-76. PubMed ID: 14646035
    [Abstract] [Full Text] [Related]

  • 9. Healthy subjects produce both anti-factor VIII and specific anti-idiotypic antibodies.
    Gilles JG, Saint-Remy JM.
    J Clin Invest; 1994 Oct; 94(4):1496-505. PubMed ID: 7523452
    [Abstract] [Full Text] [Related]

  • 10. Neutralisation of factor VIII inhibitors by anti-idiotypes isolated from phage-displayed libraries.
    Schmidt A, Brettschneider K, Kahle J, Orlowski A, Becker-Peters K, Stichel D, Schulze J, Braner M, Tampé R, Schwabe D, Königs C.
    Thromb Haemost; 2016 Jul 04; 116(1):32-41. PubMed ID: 27009573
    [Abstract] [Full Text] [Related]

  • 11. Neutralizing antiidiotypic antibodies to factor VIII inhibitors after desensitization in patients with hemophilia A.
    Gilles JG, Desqueper B, Lenk H, Vermylen J, Saint-Remy JM.
    J Clin Invest; 1996 Mar 15; 97(6):1382-8. PubMed ID: 8617869
    [Abstract] [Full Text] [Related]

  • 12. Restricted epitope specificity of anti-FVIII antibodies that appeared during a recent outbreak of inhibitors.
    Gilles JG, Peerlinck K, Arnout J, Vermylen J, Saint-Remy JM.
    Thromb Haemost; 1997 May 15; 77(5):938-43. PubMed ID: 9184406
    [Abstract] [Full Text] [Related]

  • 13. Characteristics of inhibitors in mild/moderate haemophilia A.
    Peerlinck K, Jacquemin M.
    Haemophilia; 2006 Dec 15; 12 Suppl 6():43-7. PubMed ID: 17123393
    [Abstract] [Full Text] [Related]

  • 14. Novel therapies for immune tolerance in haemophilia A.
    Collins PW.
    Haemophilia; 2006 Dec 15; 12 Suppl 6():94-100; discussion 100-1. PubMed ID: 17123401
    [Abstract] [Full Text] [Related]

  • 15. Immunoglobulin isotypes and functional anti-FVIII antibodies in response to FVIII treatment in Balb/c and C57BL/6 haemophilia A mice.
    Qadura M, Waters B, Burnett E, Chegeni R, Hough C, Othman M, Lillicrap D.
    Haemophilia; 2011 Mar 15; 17(2):288-95. PubMed ID: 21091850
    [Abstract] [Full Text] [Related]

  • 16. Immunological aspects of inhibitor development.
    Reding MT.
    Haemophilia; 2006 Dec 15; 12 Suppl 6():30-5; discussion 35-6. PubMed ID: 17123391
    [Abstract] [Full Text] [Related]

  • 17. Characterization of antibodies to factor VIII in hemophilia A patients treated by immune tolerance therapy.
    Scandella D, Reyes H, Felch M, Sakurai Y.
    Haematologica; 2000 Oct 15; 85(10 Suppl):86-8. PubMed ID: 11187882
    [Abstract] [Full Text] [Related]

  • 18. High-affinity, noninhibitory pathogenic C1 domain antibodies are present in patients with hemophilia A and inhibitors.
    Batsuli G, Deng W, Healey JF, Parker ET, Baldwin WH, Cox C, Nguyen B, Kahle J, Königs C, Li R, Lollar P, Meeks SL.
    Blood; 2016 Oct 20; 128(16):2055-2067. PubMed ID: 27381905
    [Abstract] [Full Text] [Related]

  • 19. Immune response against serial infusion of factor VIII antigen through an implantable venous-access device system in haemophilia A mice.
    Madoiwa S, Kobayashi E, Kashiwakura Y, Sakata A, Yasumoto A, Ohmori T, Mimuro J, Sakata Y.
    Haemophilia; 2012 May 20; 18(3):e323-30. PubMed ID: 22044430
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.